VANI
Vivani Medical Inc.
$1.61
-$0.08(-4.73%)
48
Overall
40
Value
75
Tech
31
Quality
Market Cap
$83.53M
Volume
581.68K
52W Range
$0.91 - $1.92
Target Price
$4.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $8.9M | $4.0M | $8.0M | $6.9M | -- | -- | -- | -- | -- | -- | ||
| Total Revenue | $8.9M | $4.0M | $8.0M | $6.9M | -- | -- | -- | -- | -- | -- | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-5.3M | $-10.1M | $-5.1M | $-4.9M | $2.2M | $500.0K | $130.0K | -- | -- | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $3.7M | $-6.1M | $2.8M | $2.0M | $-2.2M | $-500.0K | $130.0K | -- | -- | -- | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-23.7M | $-27.1M | $-31.5M | $-37.2M | $31.8M | $15.4M | $13.3M | $21.2M | $27.0M | $24.7M | ||
| Research & Development | $3.0M | $5.3M | $7.9M | $10.0M | $13.1M | $4.8M | $11.0M | $14.2M | $17.0M | $15.7M | ||
| Research Expense | $3.0M | $5.3M | $7.9M | $10.0M | $13.1M | $4.8M | $11.0M | $14.2M | $17.0M | $15.7M | ||
| Selling, General & Administrative | $17.2M | $19.1M | $20.5M | $22.0M | $15.3M | $6.6M | $2.3M | $7.1M | $10.0M | $8.9M | ||
| Selling & Marketing Expenses | $8.9M | $9.0M | $9.6M | $11.3M | $6.1M | $701.0K | -- | -- | -- | -- | ||
| General & Administrative Expenses | $8.2M | $10.1M | $10.9M | $10.7M | $9.2M | $5.9M | $2.3M | $7.1M | $10.0M | $8.9M | ||
| Salaries & Wages | $-2.7M | $-3.4M | $-3.8M | $-3.6M | $-2.9M | $421.0K | $-75.0K | -- | $13.0M | $11.8M | ||
| Depreciation & Amortization | $-335.0K | $-432.0K | $-500.0K | $-400.0K | $-400.0K | $200.0K | $300.0K | $400.0K | $400.0K | $400.0K | ||
| Depreciation & Amortization | $-335.0K | $-432.0K | $-500.0K | $-400.0K | $-400.0K | $200.0K | $-100.0K | $400.0K | $400.0K | $400.0K | ||
| Other Operating Expenses | $3.5M | $2.7M | $3.1M | $4.6M | $3.4M | $-1.7M | $378.0K | $-7.4M | $-262.0K | $-648.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-20.0M | $-33.2M | $-36.6M | $-41.5M | $-34.0M | $-14.9M | $-13.3M | $-21.2M | $-27.0M | $-24.7M | ||
| EBITDA | $-19.7M | $-32.7M | $-28.1M | $-34.7M | $-33.2M | $-8.9M | $-13.0M | $-20.9M | $-24.4M | $-22.8M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | -- | -- | -- | $10.1M | -- | ||
| Interest Income Operating | $2.0K | $31.0K | $93.0K | $86.0K | $362.0K | $16.0K | $550.0K | $475.0K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | -- | -- | -- | -- | -- | -- | -- | -- | $-10.1M | -- | ||
| Other Income/Expense | $-27.0K | -- | $-8.0M | $-6.9M | $-3.4M | -- | -- | $7.4M | $-1.3M | $-1.2M | ||
| Other Special Charges | $27.0K | -- | $8.0M | $6.9M | $3.4M | -- | -- | $6.9M | $1.3M | $1.2M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | $555.0K | $3.4M | $2.2M | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | $-555.0K | $-3.4M | $-2.2M | $700.0K | -- | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $700.0K | $-700.0K | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-9.2M | $-13.3M | $-21.2M | $-25.7M | $-23.5M | ||
| Pre-Tax Income | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-12.5M | $-12.8M | $-13.9M | $-25.7M | $-23.5M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | -- | -- | -- | -- | -- | -- | $-1.1M | -- | -- | ||
| NET INCOME | ||||||||||||
| Net Income | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-9.3M | $-12.8M | $-13.9M | $-25.7M | $-23.5M | ||
| Net Income (Continuing Operations) | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-14.9M | $-12.8M | $-13.9M | $-25.7M | $-23.5M | ||
| Net Income (Discontinued Operations) | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-9.3M | $-12.8M | $-13.9M | $-25.7M | $-23.5M | ||
| Net Income (Common Stockholders) | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-9.3M | $-12.8M | $-13.9M | $-25.7M | $-23.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-23.3M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-29.0M | $-37.2M | $-36.6M | $-42.1M | $34.0M | $15.9M | $13.3M | $21.2M | $27.0M | $24.7M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $35.6K | $39.6M | $54.2M | $8.3M | $14.7M | $20.6M | $32.8M | -- | $51.3M | $55.0K | ||
| Average Shares Outstanding (Diluted) | $35.7M | $39.5M | $53.8M | $8.3M | $14.7M | $20.6M | $32.8M | -- | $51.3M | $55.0K | ||
| Shares Outstanding | $36.0M | $56.4M | $59.9M | $124.2M | $15.7M | $23.3M | $47.1M | $58.4M | $55.0M | $59.2M | ||
| Basic EPS | -- | -- | -- | -- | -- | $-0.72 | -- | -- | $-0.50 | $-0.43 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.72 | -- | -- | -- | $-0.43 | ||
| Diluted EPS | $-0.56 | $-0.84 | $-0.53 | $-4.23 | $-2.28 | $-0.72 | $-0.27 | -- | $-0.50 | $-0.43 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-2.28 | -- | $-0.27 | -- | -- | $-0.43 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | -- | -- | -- | -- | $700.0K | -- | -- | ||
| Net Operating Interest Income Expense | $2.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $8.2M | $10.1M | $10.9M | $10.7M | $9.2M | $5.9M | $2.3M | $7.1M | $10.0M | $8.9M | ||
| Other Write Off | -- | -- | -- | $-107.0K | $-65.0K | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $8.2M | $10.1M | $10.9M | $10.7M | -- | $303.0K | $-179.0K | -- | -- | -- | ||
| Selling Expense | $8.9M | $9.0M | $9.6M | $11.3M | $6.1M | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | $555.0K | $3.4M | $2.2M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VANI | $1.61 | -4.7% | 581.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |